Bluejay Diagnostics Debt to Equity Ratio 2020-2024 | BJDX
Current and historical debt to equity ratio values for Bluejay Diagnostics (BJDX) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Bluejay Diagnostics debt/equity for the three months ending December 31, 2024 was 0.00.
| Bluejay Diagnostics Debt/Equity Ratio Historical Data | |||
|---|---|---|---|
| Date | Long Term Debt | Shareholder's Equity | Debt to Equity Ratio |
| 2024-12-31 | $0.00B | $0.01B | 0.16 |
| 2024-09-30 | $0.00B | $0.01B | 0.17 |
| 2024-06-30 | $0.00B | $0.01B | 0.26 |
| 2024-03-31 | $0.00B | $0.00B | 0.51 |
| 2023-12-31 | $0.00B | $0.00B | 0.68 |
| 2023-09-30 | $0.00B | $0.01B | 0.58 |
| 2023-06-30 | $0.00B | $0.01B | 0.33 |
| 2023-03-31 | $0.00B | $0.01B | 0.19 |
| 2022-12-31 | $0.00B | $0.01B | 0.17 |
| 2022-09-30 | $0.00B | $0.01B | 0.14 |
| 2022-06-30 | $0.00B | $0.02B | 0.09 |
| 2022-03-31 | $0.00B | $0.02B | 0.09 |
| 2021-12-31 | $0.00B | $0.02B | 0.03 |
| 2021-09-30 | $0.01B | $0.00B | -4.35 |
| 2021-06-30 | $0.00B | $0.00B | 0.00 |
| 2021-03-31 | $0.00B | $0.00B | 0.00 |
| 2020-12-31 | $0.00B | 0.00 | |
| 2020-09-30 | $0.00B | $0.00B | 0.00 |
| 2019-12-31 | $0.00B | $0.00B | -1.31 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | MED INSTRUMENTS | $0.001B | $0.000B |
| Bluejay Diagnostics Inc. is a late-stage, pre-revenue medical device company. It focused on developing near-patient products for triage, diagnosis and monitoring of disease progression. Bluejay Diagnostics Inc. is based in ACTON, Mass. | |||